CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets

CD70 – a ligand protein of CD27 on lymphocytes – is expressed in a large spectrum of malignancies. It is an attractive target for antibody-based therapy and several clinical trials are currently being conducted. However, there is no evidence regarding the expression of CD70 and its relationship with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashima, Jumpei, Hishima, Tsunekazu, Okuma, Yusuke, Horio, Hirotoshi, Ogawa, Masumi, Hayashi, Yukiko, Horiguchi, Shin-ichiro, Motoi, Toru, Ushiku, Tetsuo, Fukayama, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821901/
https://www.ncbi.nlm.nih.gov/pubmed/35145909
http://dx.doi.org/10.3389/fonc.2021.808396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821901/
https://www.ncbi.nlm.nih.gov/pubmed/35145909
http://dx.doi.org/10.3389/fonc.2021.808396

Ejemplares similares